Our Leadership

Scott Luce
Chief Executive Officer

Scott brings more than three decades of pharmaceutical industry leadership experience to SCA Pharma.

Previously, Scott was an operating partner at The Vistria Group, where he helped to develop and execute its health-care sector investment strategy. He has also held executive leadership roles in general management, sales and marketing, and business development with both Abbott and Baxter.

Scott holds a bachelor’s degree in marketing from Indiana University, and an MBA from Lake Forest Graduate School of Management.

Steven Dufort
Chief Human Resources Officer

Steven is charged with helping SCA Pharma attract, hire, develop and retain best-in-class talent for all levels of the organization.

Previously, he worked at GE in a leadership role, most recently as the human-resources leader for the organization’s gas turbine supply chain, where he supported multiple sites and 2,000 employees.

Steven earned his bachelor’s degree in business administration from SUNY Geneseo and his MBA from Union College.

Matt White
Chief Operating Officer

Matt White is the Chief Operating Officer at SCA Pharma, where he leads the company’s operations with a focus on strategic execution, cross-functional alignment, and continuous improvement. Based in Little Rock, Arkansas, Matt plays a key role in shaping the company’s long-term direction through initiatives such as strategy deployment and executive leadership planning.

As a member of the Executive Leadership Team, Matt is known for his collaborative leadership style and commitment to operational excellence. He regularly leads company-wide forums, including town halls and strategic planning sessions, to ensure transparency and alignment across teams.

Jessica Wrentz
Vice President, Sales & Customer Experience

Jessica Wrentz is a dynamic commercial leader with over a decade of experience in pharmaceutical sales, integrated delivery network (IDN) management, and customer experience strategy. As Vice President of Sales and Customer Experience at SCA Pharma, she oversees a large portfolio and leads national teams in delivering innovative, customer-first solutions across the healthcare landscape.

Jessica’s career at SCA Pharma began in 2014 and has been marked by a series of progressive leadership roles. Her expertise spans sales, marketing, finance, and operations, with a proven track record of expanding market share, optimizing contract strategies, and building high-performing teams. She is known for her strategic vision, data-driven approach, and relentless focus on customer value.

A graduate of the University of Arkansas at Little Rock, Jessica earned her BBA in Finance magna cum laude.

Racheal Adams, PharmD
Chief Pharmacy Officer

Racheal serves as a liaison with regulatory entities, strategic partners and customers. She also plays a critical role in product portfolio development.

An employee of SCA Pharma since its start, Racheal has served in multiple quality roles including director of corporate quality. With 20+ years of experience in sterile compounding, she holds certificates in primary compounding and high-risk sterile compounding.

Racheal earned her Doctor of Pharmacy degree from the University of Arkansas for Medical Sciences.

Louis Pace
Chief Financial Officer and Chief Information Officer

Louis Pace brings over 30 years of experience serving several successful private equity backed businesses in functional and leadership roles. Most recently, Mr. Pace served as Chief Financial Officer at Orchid Orthopedic Solutions where he successfully led strategy deployment efforts that focused on growth and profitability improvement.

Mr. Pace holds an AB in Economics from Harvard University and an MBA from Northwestern Kellogg Graduate School of Management.

Ken Bonnell
Chief Quality Officer

Ken Bonnell joins SCA Pharma as the Chief Quality Officer (CQO), bringing over 30 years of expertise in Quality, Operations, and Regulatory Affairs compliance. His transformative leadership at Aldevron, a Danaher Company, earned the facility a “No Action Indicated” status from the FDA, contributing significantly to the COVID-19 vaccine production. Previously, Ken held pivotal roles at Teligent Pharma, Merck, and PCI Pharma, enhancing compliance and quality standards.

Ken’s academic credentials include an M.S. in Molecular Biology from the University of Nebraska at Kearney, an M.B.A. in Business Management from Montgomery University, and a B.S. in from Mary Washington University. Ken also holds a Six Sigma Black Belt certification from Villanova University, and he has also co-authored a chapter on Orphan Diseases in the Regulatory Affairs Handbook published by RAPS.